GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FDC Ltd (BOM:531599) » Definitions » Institutional Ownership

FDC (BOM:531599) Institutional Ownership : 7.51% (As of Dec. 11, 2024)


View and export this data going back to 1996. Start your Free Trial

What is FDC Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, FDC's institutional ownership is 7.51%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, FDC's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, FDC's Float Percentage Of Total Shares Outstanding is 0.00%.


FDC Institutional Ownership Historical Data

The historical data trend for FDC's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FDC Institutional Ownership Chart

FDC Historical Data

The historical data trend for FDC can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 8.32 8.39 8.43 8.55 8.23 8.18 8.17 7.50 7.51 7.51

FDC Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


FDC Business Description

Traded in Other Exchanges
Address
106 A, J. P. Road, C-3 Skyvistas, D.N. Nagar, Near Versova Police Station, Andheri (West), Mumbai, MH, IND, 400053
FDC Ltd is principally engaged in the business of manufacturing and trading pharmaceutical products. It has its presence in numerous therapeutic segments including anti-infectives, gastrointestinal treatments, ophthalmics, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, and others. The company's different pharmaceutical products are marketed through brands such as Electral, Enerzal, Zifi, Zocon, Vitcofol, Otek Ac Neo, Amodep AT, Simyl MCT Oil, and many others. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and other regions.

FDC Headlines

No Headlines